Lab Norata

Laboratory of Pharmacology of Cardioimmunometabolic Disorders, University of Milan - Department of Pharmacological and Biomolecular Sciences (DiSFeB)

[Andrea Baragetti @AndreaBaragetti]

🔥Honored to speak at the #EAS Advanced Course on Non-Classical Risk Factors, on upfront therapeutic perspectives in cardio-renal syndrome. Thanks to @society_eas, to the organizers, for fueling this fight. ⚔️science is a weapon, innovation is a creed. @DaniloNorata @LabNorata

[Giuseppe Danilo Norata @DaniloNorata]

A terrific EAS Advanced Course on Non-Classical Risk Factor. I would like to sincerely thank the @society_eas for the opportunity to organize this event and for their continuous commitment in education. The meeting have been truly inspiring. Thanks to all friends a and colleagues

[Lab Norata @LabNorata]

Congrats to the Best Young Investigator Prize Winners – SISA Lombardia/SITECs 2025! 🏆
A special shout-out to Moretti Arianna, Laura Gullà and Marta Iaia for receiving the Best Young Investigator Prize at the SISA Lombardia/SITECs 2025 Meeting https://t.co/w76BD3vZFw

[Giuseppe Danilo Norata @DaniloNorata]

Very looking forward to welcome all the participants in Milan on Oct 30 for the EAS Advanced Course on non‑classical risk factors 🇮🇹meeting with leading experts on atherosclerosis and beyond @cj_binder @society_eas @LabNorata @AndreaBaragetti @Charis_Oxford @fabri_bon87

[Lab Norata @LabNorata]

🎓 PhD Graduation – Università degli Studi di Milano 🎓
Honored of our PhD graduates.
Congratulations to all our new PhDs — the future of science is in great hands! 🌟⁦@DaniloNorata⁩ https://t.co/5dsr6bqcA4

[Lab Norata @LabNorata]

@DaniloNorata

[European Atherosclerosis Society @society_eas]

The Scientific Programme Committee Co-chairs for EAS Congress 2026, Prof. @LabNorata and Prof. @LaleTokgozoglu, present an initial overview of the agenda and invite you to submit your research and abstracts: https://t.co/YodYCqLOjc

[Lab Norata @LabNorata]

Hot off the press! 🚀
Thrilled to share our latest publication from the lab. An exciting step forward made possible by the incredible work of our team. 🧠🔬
A huge congratulations to all contributors! 🥳
Dive into the details and enjoy the read: 📖

[Lorenzo Da Dalt @lore_ddlt]

🧬 Thrilled to share our new publication in Molecular Metabolism!

Our findings reveal a role of mitochondrial fusion in promoting lipid imbalance and vascular disease, suggesting that mitochondrial dynamics could be a novel therapeutic target in #CVD https://t.co/ZyCI95UOPw

[Francesca Mottarlini @framottarlini]

Proud to share our new paper!
… Perfect birthday “gift” ✨

Thanks to everyone who made this possible.

[Ottavia Terenghi @OTerenghi]

Just returned from the 48th European Lipoprotein Club Meeting in Tutzing.

It was an inspiring few days of science, discussion, and connection. 🔬💊

Grateful for the opportunity and the feedback received! ✨

#ELC2025 @society_eas @LabNorata

[European Atherosclerosis Society @society_eas]

Join us in Milan on October 30, for the EAS Advanced Course on non-classical risk factors. Held at the Hilton Milano 🇮🇹, this full-day event brings together leading experts to explore emerging topics in cardiovascular science - including MASLD, cardio-renal syndrome, inflammation, and gender medicine.
📋 https://t.co/8EdOjnQcYN @ProfKausikRay @KatiOorni @LabNorata

[Andrea Baragetti @AndreaBaragetti]

✌️Extra-hepatic effects of anti-pcsk9 options emerging from trials! 😎lowering LDLc as much as possible is 💯safe! proposing position for investors and developers of the novel formulations! Glad to share with @lore_ddlt @DaniloNorata @LabNorata https://t.co/afqare87jp

[Lab Norata @LabNorata]

🚀 New Review Alert! 🚀
Targeting PCSK9 beyond the liver. PCSK9 is well known for its role in cholesterol metabolism, but emerging evidence suggests its impact extends beyond the liver. ⁦@DaniloNorata⁩ ⁦@AndreaBaragetti⁩ https://t.co/8c8la2IJEX

[Lab Norata @LabNorata]

We are excited to share our latest research highlighting how neuronal PCSK9 influences synaptic ApoER2 localization, offering new insights into its role in the brain. https://t.co/lsHjbW01Ar @DaniloNorata @lore_ddlt

[Atherosclerosis @ATHjournal]

Awareness of molecular diff in ath btw ♂️ and ♀️ advances understanding of hormones, sex chromosomes, & CV risk. It helps stratify risk, guide hormone therapy in post-menopause, and impacts transgender individuals #HerHeartMatters
🔗https://t.co/xTGYkBEK9I
@society_eas @LabNorata

[Lab Norata @LabNorata]

Inspiring presentation by @DaniloNorata at the #KSHeartFail25. @KeystoneSymp

[Lab Norata @LabNorata]

Proud of our team member @lore_ddlt for being Awarded with a scholarship at the #KSHeartFail25 on the role of mitochondrial metabolism in the interplay between heart and the liver! @KeystoneSymp! Many compliments to all the awardee!

[Andrea Baragetti @AndreaBaragetti]

Glad to share this outcome🚀Multinational alliance 🇮🇹🇳🇱🇷🇺to prove potent performance of FGF5 to identify FH when 💸💸genetics is not available💥💥 The potential of A.I. is endless🤖 In search of biological relevance🧬🧫 @AL_Catapano https://t.co/2RO7XkZzi6

[Lab Norata @LabNorata]

The new manuscript from the lab and @AndreaBaragetti is out!!! Enjoy the read of Exploring neutrophils as therapeutic targets in cardiometabolic diseases: Trends in Pharmacological Sciences https://t.co/u4Mw2EIkTj

[Andrea Baragetti @AndreaBaragetti]

Huge presentation held by @DaniloNorata at SISA italian society of Atherosclerosis💣💥. Super set of data🚀 @FraaFantini. Keep posted🤙 @LabNorata

[Lab Norata @LabNorata]

Proud of @Monika_Svecla for the last published manuscript from the lab. A terrific work on the role of #ASGR1 and #glycoproteins on the development of #atherosclerosis @DaniloNorata @lore_ddlt @AndreaBaragetti @fabri_bon87

https://t.co/FpqCDYlCRD